Tropisetron improves deficits in auditory P50 suppression in schizophrenia

Schizophrenia Research

Volumn 76, Issue 1, 2005, Pages 67-72

  Koike, Kaori ^a   Hashimoto, Kenji ^a   Takai, Nobuyuki ^a   Shimizu, Eiji ^a   Komatsu, Naoya ^a   Watanabe, Hiroyuki ^a   Nakazato, Michiko ^a   Okamura, Naoe ^a   Stevens, Karen E ^b   Freedman, Robert ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Drug therapy; Evoked potentials auditory; Nicotinic receptors; Schizophrenia; Serotonin receptors; Tropisetron

Indexed keywords

FLUPHENAZINE DECANOATE; LEVOMEPROMAZINE; OLANZAPINE; PERICIAZINE; PEROSPIRONE; PIMOZIDE; QUETIAPINE; RISPERIDONE; TROPISETRON; ZOTEPINE;

ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; EVOKED POTENTIALS, AUDITORY; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; INDOLES; MALE; MIDDLE AGED; NEURAL INHIBITION; RECEPTORS, NICOTINIC; RECEPTORS, SEROTONIN, 5-HT3; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEROTONIN ANTAGONISTS;

EID: 20444483610     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.12.016     Document Type: Article

References (34)

1. L.E. Adler, E. Pachtman, R.D. Franks, M. Pecevich, M.C. Waldo, and R. Freedman Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia Biol. Psychiatry 17 1982 639 654
2. L.E. Adler, L.J. Hoffer, J. Griffith, M.C. Waldo, and R. Freedman Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics Biol. Psychiatry 32 1992 607 616
3. L.E. Adler, L.D. Hoffer, A. Wiser, and R. Freedman Normalization of auditory physiology by cigarette smoking in schizophrenic patients Am. J. Psychiatry 150 1993 1856 1861
4. Adler, L.E., Cawthra, E., Donovan, K.A., Harris, J.G., Nagamoto, H., Olincy, A., Waldo, M., in press. Ondansetron improves P50 auditory gating in medicated schizophrenic patients. Am. J. Psychiatry.
5. L.E. Adler, A. Olincy, E.C. Cawthra, K.A. McRae, J.G. Harris, H.T. Nagamoto, R. Ross, M.C. Waldo, and R. Freedman The varied effects of atypical medications on P50 auditory gating in schizophrenic patients Am. J. Psychiatry 161 2004 1822 1828
6. D.L. Braff, and R. Freedman Endophenotypes in studies of the genetics of schizophrenia K.L. Davis J.T. Coyle C. Nemeroff Neuropsychopharmacology: the fifth generation of progress 2002 Lippincott, Williams and Wilkins New York 703 716
7. D.L. Braff, and M.A. Geyer Sensorimotor gating and schizophrenia. Human and animal model studies Arch. Gen. Psychiatry 47 1990 181 188
8. B.A. Clementz, M.A. Geyer, and D.L. Braff Poor P50 suppression among schizophrenia patients and their first-degree biological relatives Am. J. Psychiatry 155 1998 1691 1694
9. S. Consolo, R. Bertorelli, G. Russi, M. Zambelli, and H. Ladinsky Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors J. Neurochem. 62 1994 2254 2261
10. J. Court, D. Spurden, and S. Lloyd Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus J. Neurochem. 73 1999 1590 1597
11. C.M. Cullum, J.G. Harris, M.C. Waldo, E. Smernoff, A. Madison, H.T. Nagamoto, J. Griffith, L.E. Adler, and R. Freedman Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia Schizophr. Res. 10 1993 131 141
12. R. Freedman, M. Hall, L.E. Adler, and S. Leonard Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia Biol. Psychiatry 38 1995 22 33
13. R. Freedman, H. Coon, M. Myles-Worsley, A. Orr-Urtreger, A. Olincy, A. Davis, M. Polymeropoulos, J. Holik, J. Hopkins, M. Hoff, J. Rosenthal, M.C. Waldo, F. Reimherr, P. Wender, J. Yaw, D.A. Young, C.R. Breese, C. Adams, D. Patterson, L.E. Adler, L. Kruglyak, S. Leonard, and W. Byerley Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus Proc. Natl. Acad. Sci. U. S. A. 94 1997 587 592
14. R. Freedman, C.E. Adams, and S. Leonard The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia J. Chem. Neuroanat. 20 2000 299 306
15. M.G. Giovannini, I. Ceccarelli, B. Molinari, M. Cecchi, J. Goldfarb, and P. Blandina Serotonergic modulation of acetylcholine release from cortex of freely moving rats J. Pharmacol. Exp. Ther. 285 1998 1219 1225
16. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153 1996 321 330
17. Z.Z. Guan, X. Zhang, K. Blennow, and A. Nordberg Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain NeuroReport 10 1999 1779 1782
18. J.G. Harris, S. Kongs, D. Allensworth, L. Martin, J. Tregellas, B. Sullivan, G. Zerbe, and R. Freedman Effects of nicotine on cognitive deficits in schizophrenia Neuropsychopharmacology 29 2004 1378 1385
19. J. Ichikawa, J. Dai, I.A. O'Laughlin, W.L. Fowler, and H.Y. Meltzer Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum Neuropsychopharmacology 26 2002 325 339
20. L.K. Jacobsen, D.C. D'Souza, W.E. Menci, K.R. Pugh, P. Skudlarski, and J.H. Krystal Nicotine effects on brain function and functional connectivity in schizophrenia Biol. Psychiatry 55 2004 850 858
21. F. Kees, L. Farber, M. Bucher, G. Mair, K. Morike, and H. Grobecker Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteers Br. J. Clin. Pharmacol. 52 2001 705 707
22. J.E. Leysen, W. Gommeren, and A. Schotte Serotonin receptor subtypes: possible roles and implications in antipsychotic drug action M. Awounters Serotonin in antipsychotic treatment-mechanism and clinical practice 1996 Marcel Dekker Inc. New York 51 75
23. G.A. Light, M.A. Geyer, B.A. Clementz, K.S. Cadenhead, and D.L. Braff Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications Am. J. Psychiatry 157 2000 767 771
24. J.E. Macor, D. Gurley, T. Lanthorn, J. Loch, R.A. Mack, G. Mullen, O. Tran, N. Wright, and J.C. Gordon The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist Bioorg. Med. Chem. Lett. 11 2001 319 321
25. A.V. Maricq, A.S. Peterson, A.J. Brake, R.M. Myers, and D. Julius Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel Science 254 1991 432 437
26. G. Maura, G.C. Andrioli, P. Cavazzani, and M. Raiteri 5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release J. Neurochem. 58 1992 2334 2337
27. C.S. Myers, O. Robles, A.N. Kakoyannis, J.D. Sherr, M.T. Avila, T.A. Blaxton, and G.K. Thaker Nicotine improves delayed recognition in schizophrenic patients Psychopharmacology 174 2004 334 340
28. R.L. Papke, J.K. Porter-Papke, and G.M. Rose Activity of alpha7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes Bioorg. Med. Chem. Lett. 14 2004 1849 1853
29. G. Raux, F. Bonnet-Brilhault, and S. Louchart The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit Mol. Psychiatry 7 2002 1006 1011
30. J.K. Simosky, K.E. Stevens, and R. Freedman Nicotinic agonists and psychosis Curr. Drug Target CNS Neurol. Disord. 1 2002 149 162
31. J.K. Simosky, K.E. Stevens, L.E. Adler, and R. Freedman Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism Psychopharmacology (Berl.) 165 2003 386 396
32. K. Simpson, C.M. Spencer, and K.J. McClellan Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting Drugs 59 2000 1297 1315
33. R.C. Smith, A. Singh, M. Infante, A. Khandat, and A. Kloos Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia Neuropsychopharmacology 27 2002 479 497
34. P.H. Venables Input dysfunction in schizophrenia B.A. Maher Progress in experimental personality research 1967 Academic Press Orlando, FL 1 64